Cancer

Items 701-710 of 992

per page
Set Descending Direction
  1. Nampt (Visfatin/PBEF) (human) (rec.) (His) (BULK)
    AG-40A-0018AA
    AG-40A-0018AA-C500500 µg
    CHF 2'800.00
    Measurement of NAMPT enzymatic activity was performed as described previously [G.C. Elliott, et al.; Anal Biochem 107, 199 (1980)]. The recombinant Nampt was diluted in assay buffer and 10μl per 50μl reaction mix were applied in the reaction mix (20
  2. Nampt (Visfatin/PBEF) (mouse) (rec.)
    AG-40A-0056Y
    AG-40A-0056Y-C01010 µg
    CHF 155.00
    AG-40A-0056Y-30103 x 10 µg
    CHF 310.00
    Replaces AG-40A-0056
  3. Nampt (Visfatin/PBEF) (mouse) (rec.) (His)
    AG-40A-0017
    AG-40A-0017-C05050 µg
    CHF 420.00
    Insulin-mimetic effects on stimulated differentiating 3T3-L1 cells. 
10μg/ml Nampt (mouse) (rec.) (His) (Prod. No. AG-40A-0017) or human insulin was added to differentiating 3T3-L1 cells that had been stimulated with 1μM dexamethasone and 0.5m
  4. Nampt (Visfatin/PBEF) (rat) (rec.)
    AG-40A-0058
    AG-40A-0058-C01010 µg
    CHF 205.00
    AG-40A-0058-C05050 µg
    CHF 470.00
  5. Narciclasine
    CAS  29477-83-6
    AG-CN2-0524
    AG-CN2-0524-C500500 µg
    CHF 90.00
    AG-CN2-0524-M0011 mg
    CHF 160.00
    Narciclasine
  6. Necrostatin-1
    CAS  4311-88-0
    AG-CR1-2900
    AG-CR1-2900-M0055 mg
    CHF 60.00
    AG-CR1-2900-M02525 mg
    CHF 180.00
    Necrostatin-1
  7. Necrostatin-5
    CAS  337349-54-9
    AG-CR1-0049
    AG-CR1-0049-M0055 mg
    CHF 55.00
    AG-CR1-0049-M02525 mg
    CHF 220.00
    Necrostatin-5
  8. Necrostatin-7
    CAS  351062-08-3
    AG-CR1-0054
    AG-CR1-0054-M0055 mg
    CHF 110.00
    AG-CR1-0054-M02525 mg
    CHF 385.00
    Necrostatin-7
  9. Neobavaisoflavone
    CAS  41060-15-5
    AG-CN2-0498
    AG-CN2-0498-M0011 mg
    CHF 220.00
    Neobavaisoflavone
  10. Neoxaline
    CAS  71812-10-7
    AG-CN2-0154
    AG-CN2-0154-M0011 mg
    CHF 240.00
    AG-CN2-0154-M0055 mg
    CHF 960.00
    Neoxaline

Items 701-710 of 992

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.